Author

Abigail L. Lauterbach

University of ChicagoORCID 0000-0001-8271-8777Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Ani SolankiiD· 2 shared Jeffrey A. HubbelliD· 2 shared Kirsten C. RefvikiD· 2 shared Aaron T. AlpariD· 1 shared Anna J. SlezakiD· 1 shared Brendan Thomas Kane Berg· 1 shared Colleen FoleyiD· 1 shared Erica BudinaiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Ani SolankiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintSep 14, 2026

Albumin-fused interleukin-10 prevents experimental autoimmune encephalomyelitis by promoting immunoregulation in the secondary lymphoid organs

Erica Budina, Joseph W. Reda, Kirsten C. Refvik…·Jeffrey A. Hubbell

This study shows that albumin-fused IL-10 reduces experimental autoimmune encephalomyelitis by enhancing immunoregulation in secondary lymphoid organs.

DOI 10.64898/2026.04.10.717764

mousebulk RNA-seq

𝕏 PostBluesky

BioengineeringbioRxivPreprintMar 21, 2024

Engineered Flt3L Drives Tolerogenic State to Attenuate Anti-drug Antibody Responses

Aaron T. Alpar, Rachel P. Wallace, Kirsten C. Refvik…·Jeffrey A. Hubbell

The paper describes a method using engineered Flt3L to induce a tolerogenic immune state, reducing anti-drug antibodies to a fungal enzyme.

DOI 10.1101/2024.03.21.586168

humanproteomics

𝕏 PostBluesky